- Home
- APLT vs LASE Comparison
APLT vs LASE Comparison
Compare APLT & LASE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- LASE
- Stock Information
- Founded
- APLT 2016
- LASE 2019
- Country
- APLT United States
- LASE United States
- Employees
- APLT N/A
- LASE N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- LASE Industrial Machinery/Components
- Sector
- APLT Health Care
- LASE Industrials
- Exchange
- APLT Nasdaq
- LASE Nasdaq
- Market Cap
- APLT 44.0M
- LASE 51.8M
- IPO Year
- APLT 2019
- LASE 2022
- Fundamental
- Price
- APLT $0.45
- LASE $2.78
- Analyst Decision
- APLT Buy
- LASE
- Analyst Count
- APLT 7
- LASE 0
- Target Price
- APLT $6.10
- LASE N/A
- AVG Volume (30 Days)
- APLT 1.6M
- LASE 475.1K
- Earning Date
- APLT 08-11-2025
- LASE 07-07-2025
- Dividend Yield
- APLT N/A
- LASE N/A
- EPS Growth
- APLT N/A
- LASE N/A
- EPS
- APLT N/A
- LASE N/A
- Revenue
- APLT $265,000.00
- LASE $4,962,487.00
- Revenue This Year
- APLT $415.60
- LASE N/A
- Revenue Next Year
- APLT $1,323.96
- LASE N/A
- P/E Ratio
- APLT N/A
- LASE N/A
- Revenue Growth
- APLT N/A
- LASE 23.87
- 52 Week Low
- APLT $0.30
- LASE $1.72
- 52 Week High
- APLT $10.62
- LASE $19.80
- Technical
- Relative Strength Index (RSI)
- APLT 53.55
- LASE 47.46
- Support Level
- APLT $0.46
- LASE $2.74
- Resistance Level
- APLT $0.54
- LASE $3.09
- Average True Range (ATR)
- APLT 0.05
- LASE 0.31
- MACD
- APLT -0.00
- LASE -0.06
- Stochastic Oscillator
- APLT 53.66
- LASE 2.97
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About LASE Laser Photonics Corporation
Laser Photonics Corp is an integrated manufacturing company for photonics-based industrial products and solutions, laser cleaning technologies. Its laser-blasting technologies are focused on disrupting the sandblasting and abrasives blasting markets. The company offers a portfolio of integrated laser-blasting solutions for corrosion control, rust removal, de-coating, pre-welding and post-welding, laser cleaning, and surface conditioning. Its laser-blasting solutions are applicable in every industry dealing with materials processing, including automotive, aerospace, healthcare, consumer products, shipbuilding, aerospace, machine manufacturing, nuclear maintenance and de-commissioning, and surface coating.